Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and n-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure

Journal of International Medical Research

Volumn 37, Issue 6, 2009, Pages 1831-1841

  Zhao, Y T ^a   Shao, L ^a   Teng, L L ^a   Hu, B ^a   Luo, Y ^a   Yu, X ^a   Zhang, D F ^a   Zhang, Hua ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Elderly people; Heart failure; Inflammatory markers; n 3 fatty acids; n terminal pro brain natriuretic peptide

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; OMEGA 3 FATTY ACID; PLACEBO; VASCULAR CELL ADHESION MOLECULE 1;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLEEDING; BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

EID: 74949090172     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700619     Document Type: Article

References (34)

1. Hodges P: Heart failure: epidemiologic update. Crit Care Nurs Q 2009; 32: 24-32.
2. Gu DF, Huang GY, He J, et al: Investigation of prevalence and distributing feature of chronic heart failure Chinese adult population. Chin J Cardiol 2003; 31: 3-6 [in Chinese].
3. Stewart S, MacIntyre K, Hole DJ, et al: More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322.
4. Mann DL, Young JB: Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897-904.
5. Yndestad A, Damås JK, Oie E, et al: Systemic inflammation in heart failure - the whys and wherefores. Heart Fail Rev 2006; 11: 83-92.
6. Adamopoulos S, Parissis JT, Kremastinos DT: A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 2001; 3: 517-526.
7. Yamagishi K, Iso H, Date C, et al: Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008; 52: 988-996.
8. Tavazzi L, Maggioni AP, Marchioli R, et al on behalf of the GISSI-HF Investigators: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1223-1230.
9. Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83(6 suppl): 1505S-1519S.
10. Harris WS, Miller M, Tighe AP, et al: Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008; 197: 12-24.
11. Li D: Omega-3 fatty acids and noncommunicable diseases. Chin Med J (Engl) 2003; 116: 453-458.
12. Daniels LB, Maisel AS: Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-2368.
13. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al: The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-954.
14. Mann DL: Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002; 91: 988-998.
15. Bozkurt B, Kribbs SB, Clubb FJ Jr, et al: Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-1391.
16. Anker SD, von Haehling S: Inflammatory mediators in chronic heart failure: an overview. Heart 2004; 90: 464-470.
17. Mehra MR, Lavie CJ, Ventura HO, et al: Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant 2006; 25: 834-838.
18. Li W, Gan R, Sun G: Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling. Chin Med J (Engl) 2002; 115: 1166-1169.
19. Mousa SA, Goncharuk O, Miller D: Recent advances of TNF-α antagonists in rheumatoid arthritis and chronic heart failure. Expert Opin Biol Ther 2007; 7: 617-625.
20. Yndestad A, Damås JK, Øie E, et al: Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007; 9: 236-241.
21. Seta Y, Shan K, Bozkurt B, et al: Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996; 2: 243-249.
22. Ferrucci L, Cherubini A, Bandinelli S, et al: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439-446.
23. Tsutamoto T, Hisanaga T, Fukai D, et al: Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995; 76: 803-808.
24. Paulo MC, Andrade AM, Andrade ML, et al: Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects. Nutr Metab Cardiovasc Dis 2008; 18: 664-670.
25. Collie-Duguid ES, Wahle KW: Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 1996; 220: 969-974.
26. Johansen O, Seljeflot I, Høstmark AT, et al: The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1681-1686.
27. de Lemos JA, Hennekens CH, Ridker PM: Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol 2000; 36: 423-426.
28. Tappia PS, Troughton KL, Langley-Evans SC, et al: Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond) 1995; 88: 485-489.
29. Yang SR, Chida AS, Bauter MR, et al: Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 291: L46-L57.
30. Ciubotaru I, Lee YS, Wander RC: Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003; 14: 513-521.
31. Khan SA, Vanden Heuvel JP: Role of nuclear receptors in the regulation of gene expression by dietary fatty acids. J Nutr Biochem 2003; 14: 554-567.
32. Takano H, Komuro I: Peroxisome proliferator-activated receptor γ and cardiovascular diseases. Circ J 2009; 73: 214-220.
33. Straus DS, Glass CK: Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007; 28: 551-558.
34. Grabellus F, Levkau B, Sokoll A, et al: Reversible activation of nuclear factor-κB in human endstage heart failure after left ventricular mechanical support. Cardiovasc Res 2002; 53: 124-130.